Who
Don M. Hardison
Director
Company insider
Files Form 4 as: Director, MDxHealth SA; Director, Cytek Biosciences; Director, Htg Molecular Diagnostics; EVP, Labcorp Holdings; President, CEO and Director, Exact Sciences.
In numbers
- Trades disclosed
- 34
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $146K
- Companies
- 5
- Companies where not an officer
- 3
- First trade
- 16 Feb 2006
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | MDXH MDxHealth SAoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | MDXH MDxHealth SAoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code M | —15,706 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | CTKB Cytek BiosciencesLife-science tools | SEC FORM 4 Code M | —15,706 | filing |
| 5 Jun 2024filed 7 Jun 2024 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code A | —15,706 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code A | —23,076 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code A | —30,242 at $0.00 | filing |
| 15 Sep 2022filed 15 Sep 2022 | Htg Molecular Diagnosticsoption or derivative | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | CTKB Cytek Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code A | —47,013 at $0.00 | filing |
| 18 Aug 2021filed 19 Aug 2021 | Htg Molecular Diagnosticsoption or derivative | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
| 19 Aug 2020filed 21 Aug 2020 | Htg Molecular Diagnosticsoption or derivative | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 14 Aug 2019filed 16 Aug 2019 | Htg Molecular Diagnosticsoption or derivative | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 14 Aug 2019filed 16 Aug 2019 | Htg Molecular Diagnostics | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 15 Aug 2018filed 17 Aug 2018 | Htg Molecular Diagnosticsoption or derivative | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 15 Aug 2018filed 17 Aug 2018 | Htg Molecular Diagnostics | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 23 Aug 2017filed 24 Aug 2017 | Htg Molecular Diagnostics | SEC FORM 4 Code A | $15K7,500 at $2.05 | filing |
| 15 Aug 2017filed 16 Aug 2017 | Htg Molecular Diagnosticsoption or derivative | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 25 Aug 2016filed 29 Aug 2016 | Htg Molecular Diagnosticsoption or derivative | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 2 May 2016filed 3 May 2016 | Htg Molecular Diagnosticsoption or derivative | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 31 Dec 2009filed 15 Jan 2010 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $288K3,848 at $74.84 | filing |
News
Labcorp Holdings Inc. (NYSE:LH) Shares to Pay Quarterly Dividend of $0.72LH · dailypolitical.com · 21 Oct 2026Labcorp To Buy Myriad Genetics' Prenatal Testing Business For $210 MlnLH · finanzen.ch · 20 Oct 2026Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35%LH · rttnews.com · 15 Oct 2026
0 headlines in the last 90 days name Don M. Hardison; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.